323 related articles for article (PubMed ID: 16984923)
41. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression.
Johnson DG; Ohtani K; Nevins JR
Genes Dev; 1994 Jul; 8(13):1514-25. PubMed ID: 7958836
[TBL] [Abstract][Full Text] [Related]
42. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
Mann DJ; Jones NC
Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
[TBL] [Abstract][Full Text] [Related]
43. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
Wunderlich M; Berberich SJ
Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
[TBL] [Abstract][Full Text] [Related]
44. Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product.
Zacksenhaus E; Jiang Z; Phillips RA; Gallie BL
EMBO J; 1996 Nov; 15(21):5917-27. PubMed ID: 8918469
[TBL] [Abstract][Full Text] [Related]
45. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
Ofir M; Hacohen D; Ginsberg D
Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
[TBL] [Abstract][Full Text] [Related]
46. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
[TBL] [Abstract][Full Text] [Related]
47. Expression of MCM10 and TopBP1 is regulated by cell proliferation and UV irradiation via the E2F transcription factor.
Yoshida K; Inoue I
Oncogene; 2004 Aug; 23(37):6250-60. PubMed ID: 15195143
[TBL] [Abstract][Full Text] [Related]
48. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis.
Ebelt H; Hufnagel N; Neuhaus P; Neuhaus H; Gajawada P; Simm A; Müller-Werdan U; Werdan K; Braun T
Circ Res; 2005 Mar; 96(5):509-17. PubMed ID: 15718499
[TBL] [Abstract][Full Text] [Related]
49. Identification and characterization of novel isoforms of human DP-1: DP-1{alpha} regulates the transcriptional activity of E2F1 as well as cell cycle progression in a dominant-negative manner.
Ishida H; Masuhiro Y; Fukushima A; Argueta JG; Yamaguchi N; Shiota S; Hanazawa S
J Biol Chem; 2005 Jul; 280(26):24642-8. PubMed ID: 15863509
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of E2F5/p130, but not E2F5 alone, can inhibit E2F-induced cell cycle entry in transgenic mice.
Chen Q; Liang D; Overbeek PA
Mol Vis; 2008 Mar; 14():602-14. PubMed ID: 18385796
[TBL] [Abstract][Full Text] [Related]
51. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
[TBL] [Abstract][Full Text] [Related]
52. The central acidic domain of MDM2 is critical in inhibition of retinoblastoma-mediated suppression of E2F and cell growth.
Sdek P; Ying H; Zheng H; Margulis A; Tang X; Tian K; Xiao ZX
J Biol Chem; 2004 Dec; 279(51):53317-22. PubMed ID: 15485814
[TBL] [Abstract][Full Text] [Related]
53. Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A.
Sinha A; Faller DV; Denis GV
Biochem J; 2005 Apr; 387(Pt 1):257-69. PubMed ID: 15548137
[TBL] [Abstract][Full Text] [Related]
54. Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315.
Fogal V; Hsieh JK; Royer C; Zhong S; Lu X
EMBO J; 2005 Aug; 24(15):2768-82. PubMed ID: 16037820
[TBL] [Abstract][Full Text] [Related]
55. TRIP-Br links E2F to novel functions in the regulation of cyclin E expression during cell cycle progression and in the maintenance of genomic stability.
Sim KG; Zang Z; Yang CM; Bonventre JV; Hsu SI
Cell Cycle; 2004 Oct; 3(10):1296-304. PubMed ID: 15467469
[TBL] [Abstract][Full Text] [Related]
56. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.
Flemington EK; Speck SH; Kaelin WG
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):6914-8. PubMed ID: 8346196
[TBL] [Abstract][Full Text] [Related]
57. Regulation of E2F1 activity by acetylation.
Martínez-Balbás MA; Bauer UM; Nielsen SJ; Brehm A; Kouzarides T
EMBO J; 2000 Feb; 19(4):662-71. PubMed ID: 10675335
[TBL] [Abstract][Full Text] [Related]
58. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Hiyama H; Iavarone A; Reeves SA
Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
[TBL] [Abstract][Full Text] [Related]
59. Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation.
Xia X; Cheng A; Lessor T; Zhang Y; Hamburger AW
J Cell Physiol; 2001 May; 187(2):209-17. PubMed ID: 11268000
[TBL] [Abstract][Full Text] [Related]
60. [Differences in human and rat FSH receptors promote activity as a result of the transcriptional factors: E2F1, E2F4 and E2F5 overexpression].
Putowski L; Gasior W; Gogacz M; Gagała J; Jakowicki JA
Ginekol Pol; 2001 Dec; 72(12A):1560-6. PubMed ID: 11883315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
